Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Menthol cigarette smoking among individuals in treatment for substance use disorders.

Gubner NR, Williams DD, Pagano A, Campbell BK, Guydish J.

Addict Behav. 2018 May;80:135-141. doi: 10.1016/j.addbeh.2018.01.015. Epub 2018 Feb 4.

PMID:
29407684
2.

Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.

Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, Hays JT.

Drug Alcohol Depend. 2018 Mar 1;184:12-17. doi: 10.1016/j.drugalcdep.2017.11.017. Epub 2018 Jan 2.

PMID:
29324248
3.

Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking.

Beckham JC, Adkisson KA, Hertzberg J, Kimbrel NA, Budney AJ, Stephens RS, Moore SD, Calhoun PS.

Addict Behav. 2018 Apr;79:86-92. doi: 10.1016/j.addbeh.2017.12.007. Epub 2017 Dec 6.

PMID:
29268146
4.

Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.

O'Malley SS, Zweben A, Fucito LM, Wu R, Piepmeier ME, Ockert DM, Bold KW, Petrakis I, Muvvala S, Jatlow P, Gueorguieva R.

JAMA Psychiatry. 2018 Feb 1;75(2):129-138. doi: 10.1001/jamapsychiatry.2017.3544.

PMID:
29261824
5.

Addiction Treatment Clients' Reactions to Graphic Warning Labels on Cigarette Packs.

Pagano A, Gubner N, Tajima B, Yip D, Henderson C, Guydish J.

J Drug Issues. 2017 Jul;47(3):433-447. doi: 10.1177/0022042617699196. Epub 2017 Mar 20.

PMID:
29176913
6.

Use of Smoking Cessation Methods Among Patients Receiving Office-based Buprenorphine Maintenance Treatment.

Shah PA, Cunningham CO, Brisbane MT, DeLuca JP, Nahvi S.

J Addict Med. 2017 Nov/Dec;11(6):494-497. doi: 10.1097/ADM.0000000000000356.

PMID:
28885300
7.

Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016.

Guydish J, Yip D, Le T, Gubner NR, Delucchi K, Roman P.

Drug Alcohol Depend. 2017 Oct 1;179:355-361. doi: 10.1016/j.drugalcdep.2017.06.041. Epub 2017 Aug 1.

PMID:
28844012
8.

Development and preliminary pilot evaluation of a brief tablet computer intervention to motivate tobacco quitline use among smokers in substance use treatment.

Brown RA, Hecht J, Bloom EL, Minami H, Kahler CW, Abrantes AM, Dubreuil ME, Gordon A, Price LH, Ondersma SJ.

Am J Addict. 2017 Sep;26(6):587-594. doi: 10.1111/ajad.12559. Epub 2017 Aug 11.

PMID:
28800182
9.

Factors associated with nicotine dependence during methadone maintenance treatment: findings from a multisite survey in Vietnam.

Do HP, Nguyen LH, Thi Nguyen NP, Ngo C, Thi Nguyen HL, Le GT, Nguyen LK, Nguyen CT, Tran BX, Le HT, Vu TMT, Phan HTT, Tran TD, Latkin CA, Dunne MP.

BMJ Open. 2017 Jul 17;7(7):e015889. doi: 10.1136/bmjopen-2017-015889.

10.

Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency.

Gubner NR, Guydish J, Humfleet GL, Benowitz NL, Hall SM.

Drug Alcohol Depend. 2017 Sep 1;178:267-270. doi: 10.1016/j.drugalcdep.2017.05.020. Epub 2017 Jun 23.

PMID:
28683421
11.

Adherence to methadone maintenance treatment and associated factors among patients in Vietnamese mountainside areas.

Nguyen LH, Nguyen HTT, Nguyen HLT, Tran BX, Latkin CA.

Subst Abuse Treat Prev Policy. 2017 Jun 8;12(1):31. doi: 10.1186/s13011-017-0115-4.

12.

A Comparison of Daily Versus Weekly Electronic Cigarette Users in Treatment for Substance Abuse.

Gubner NR, Pagano A, Tajima B, Guydish J.

Nicotine Tob Res. 2018 Apr 2;20(5):636-642. doi: 10.1093/ntr/ntx116.

PMID:
28575519
13.

Addressing tobacco in Australian alcohol and other drug treatment settings: a cross-sectional survey of staff attitudes and perceived barriers.

Skelton E, Tzelepis F, Shakeshaft A, Guillaumier A, Dunlop A, McCrabb S, Palazzi K, Bonevski B.

Subst Abuse Treat Prev Policy. 2017 May 2;12(1):20. doi: 10.1186/s13011-017-0106-5.

14.

Evaluation of Tobacco Control Policies in San Francisco Homeless Housing Programs.

Sung H, Apollonio DE.

Health Promot Pract. 2017 Jul;18(4):571-580. doi: 10.1177/1524839917705128. Epub 2017 Apr 24.

15.

Tobacco Use Disorder Among Patients With Smoking-related Chronic Medical Disease: Association With Comorbid Substance Use Disorders.

Manhapra A, Rosenheck R.

J Addict Med. 2017 Jul/Aug;11(4):293-299. doi: 10.1097/ADM.0000000000000311.

PMID:
28368906
16.

Substance Use and Associated Health Conditions throughout the Lifespan.

Schulte MT, Hser YI.

Public Health Rev. 2014;35(2). pii: https://web-beta.archive.org/web/20150206061220/http://www.publichealthreviews.eu/upload/pdf_files/14/00_Schulte_Hser.pdf.

17.

Psychopharmacology of Tobacco and Alcohol Comorbidity: a Review of Current Evidence.

Adams S.

Curr Addict Rep. 2017;4(1):25-34. doi: 10.1007/s40429-017-0129-z. Epub 2017 Feb 18. Review.

18.

Cigarette Smoking Is Associated With Increased Risk of Substance Use Disorder Relapse: A Nationally Representative, Prospective Longitudinal Investigation.

Weinberger AH, Platt J, Esan H, Galea S, Erlich D, Goodwin RD.

J Clin Psychiatry. 2017 Feb;78(2):e152-e160. doi: 10.4088/JCP.15m10062.

19.

Drug abuse staff and clients smoking together: A shared addiction.

Guydish J, Le T, Campbell B, Yip D, Ji S, Delucchi K.

J Subst Abuse Treat. 2017 May;76:64-68. doi: 10.1016/j.jsat.2017.01.014. Epub 2017 Jan 28.

PMID:
28143680
20.

Perceived barriers to smoking cessation among adults with substance use disorders.

McHugh RK, Votaw VR, Fulciniti F, Connery HS, Griffin ML, Monti PM, Weiss RD.

J Subst Abuse Treat. 2017 Mar;74:48-53. doi: 10.1016/j.jsat.2016.12.008. Epub 2016 Dec 30.

Supplemental Content

Support Center